Further in vivo experiments confirmed the regulatory role of ANO6 (TMEM16F) in GIST progression, as evidenced by the reduction in tumor volume and weights after ANO6-plasmid treatment. This evidence concerns the gene ANO6 and gastrointestinal stromal tumor.